PCP questions use of DAP funds in stem cell research-A A +A
Thursday, July 17, 2014
THE Philippine College of Physicians (PCP) is questioning the use of about P70 million sourced from the controversial Disbursement Acceleration Program (DAP) in funding the research of stem cell treatment.
Dr. Anthony Leachon, PCP president, said it is questionable why the government would put premium in giving allocation to a scientific research instead of something more useful to the public.
"We can see that the government is bent on pursuing research for stem cell. Malacañang has repeatedly said that the DAP was undertaken in good faith to boost the country’s economic performance. Clearly, stem cell research is not urgently needed and will not affect our economic performance," Leachon said.
In the past, the PCP has been warning the people that stem cell therapy is still in its experimental stage amid its growing popularity.
They said resorting to stem cell treatment poses serious safety issues to unknowing patients when used without the necessary scientific study.
The PCP said the DOH should have just used the said amount into something certainly more useful to the public.
"This could have been provided to scientifically-proven treatment for top fatal ailments and upgrade of public hospitals for the poor," said Leachon.
Earlier, the Department of Health (DOH) disclosed that it received P3.4 billion from the DAP covering the years 2011 and 2012 and were used for the Kalusugan Pangkalahatan program of the Aquino administration.
The DAP funds, according to Health Secretary Enrique Ona, were adequately used to enroll indigent families to PhilHealth, deploy nurses under the Registered Nurses for Health Enhancement and Local Service, to finance health infrastructure development in the Autonomous Region in Muslim Mindanao, provide financial assistance to indigent patients, and to augment Maintenance and Other Operating Expenses and Capital Outlay requirements of different public hospitals. (HDT/Sunnex)